Cargando…
Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports
There is heterogeneity in cancer patients’ responses to immune checkpoint inhibitors (ICIs), including hyperprogression, which is very rapid tumor progression following immunotherapy, and pseudoprogression, which is an initial increase followed by a decrease in tumor burden or in the number of tumor...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087252/ https://www.ncbi.nlm.nih.gov/pubmed/35469479 http://dx.doi.org/10.1177/03000605221094274 |